Regulatory News
Monday, April 25, 2016
U.S. panel finds Sarepta muscular dystrophy drug not proven effective
April 25 (Reuters) - An experimental drug to treat Duchenne
muscular dystrophy, a devastating degenerative disease that
mostly affects young boys, was not supported by enough evidence
to prove it is...
Read more
No comments:
Post a Comment
‹
›
Home
View web version
No comments:
Post a Comment